Overview and Scope
Exosomes refer to the smallest EVs (extracellular vesicles) and are of particular interest in the tumor microenvironment (TME), where they have been shown to directly mediate angiogenesis, tumor metastasis, and immunosuppression. EVs can be classified into three main groups based on size, biogenesis, and function.
Sizing and Forecast
The exosome research market size has grown exponentially in recent years. It will grow from $210.62 billion in 2023 to $283.43 billion in 2024 at a compound annual growth rate (CAGR) of 34.6%. The growth in the historic period can be attributed to growing understanding of exosome biology, increasing investment in life sciences research, emergence of liquid biopsies, increased focus on personalized medicine, collaborative research initiatives.
The exosome research market size is expected to see exponential growth in the next few years. It will grow to $865.26 billion in 2028 at a compound annual growth rate (CAGR) of 32.2%. The growth in the forecast period can be attributed to clinical translation of exosome-based therapeutics, expansion of liquid biopsy applications, increased industry collaboration in research, rising interest in extracellular vesicles (evs), focus on standardization and quality control. Major trends in the forecast period include clinical applications and therapeutics, technological advancements in isolation and analysis, biomarker discovery and diagnostics, standardization and quality control, collaborations and partnerships.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/exosome-research-global-market-report
Segmentation & Regional Insights
The exosome research market covered in this report is segmented –
1) By Product: Kits And Reagents, Instruments, Other Products
2) By Indication: Cancer, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Other Indications
3) By Application: Biomarkers, Vaccine Development, Tissue Regeneration, Other Applications
4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinical Testing Laboratories
North America was the largest region in the exosome research market in 2023. The regions covered in the exosome research market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10139&type=smp
Major Driver Impacting Market Growth
The increased incidence of chronic medical diseases is expected to propel the growth of the exosome research market going forward. Chronic diseases typically last three months or longer and can deteriorate over time. Cancer, heart disease, stroke, diabetes, and arthritis are among the most common chronic diseases. It has been demonstrated that infections can use exosome release as a means of infection by altering the exosomes produced by the host to avoid detection by the immune system, thus driving demand for exosome research. Exosomes help to treat various diseases such as cancer, neurodegenerative disorders, and inflammatory conditions. For instance, in July 2022, the Centers for Disease Control and Prevention, a US-based national public health agency defined that every 6 out of 10 Americans have chronic diseases, and 4 out of 10 adults are suffering from more than two chronic diseases, like chronic lung cancer, heart disease, stroke, and diabetes. Therefore, the increased incidence of chronic medical diseases will drive the growth of the exosome research market.
Key Industry Players
Major companies operating in the exosome research market report are Thermo Fisher Scientific Inc., System Biosciences LLC, QIAGEN N.V., Exosome Diagnostics Inc., Bio-Techne Corporation, Hitachi Ltd., Aethlon Medical Inc., NanoSomiX Inc., Malvern Panalytical Ltd., Sistemic Scotland Limited, NX PharmaGen Corporation, Miltenyi Biotec GmbH, AMS Biotechnology (Europe) B.V., Norgen Biotek Corp., Novus Biologicals LLC, Lonza Group AG, Sistem-Bio S.A.S., Izon Science Ltd, Evomic Science LLC, New England Biolabs Inc., Evox Therapeutics Limited, Codiak BioSciences Inc., MagBio Genomics Inc., Cell Guidance Systems Ltd., Aruna Biomedical PBC, CureMetrix Inc., Capricor Therapeutics Inc., Stemcell Technologies Inc., ExoCoBio Inc., Creative Biolabs, ArcherDX Inc., Nanovex Biotechnologies S.L.
The exosome research market report table of contents includes:
1. Executive Summary
2. Exosome Research Market Characteristics
3. Exosome Research Market Trends And Strategies
4. Exosome Research Market – Macro Economic Scenario
5. Global Exosome Research Market Size and Growth
….
31. Global Exosome Research Market Competitive Benchmarking
32. Global Exosome Research Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Exosome Research Market
34. Exosome Research Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
